The distinct molecular background of astrocytomas WHO grade II and III as well as secondary glioblastomas WHO grade IV can be proven by revealing IDH1 mutations in codon 132 and IDH2 mutations in codon 172 [8]. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).